Home

Press Releases

12345678910
Rocky Brands, Inc. to Report Third Quarter 2025 Results on October 28, 2025
Rocky Brands, Inc. (NASDAQ: RCKY) today announced that the company will release its financial results for the third quarter ended September 30, 2025, after the market close on Tuesday, October 28, 2025. Management will host a conference call that afternoon (October 28, 2025) at 4:30 p.m. ET to discuss the financial results.
By Rocky Brands, Inc. · Via Business Wire · October 21, 2025
Beyond Meat® to Report Third Quarter 2025 Financial Results on November 4, 2025
EL SEGUNDO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the third quarter ended September 27, 2025 on Tuesday, November 4, 2025 after market close.
By Beyond Meat, Inc. · Via GlobeNewswire · October 21, 2025
Toast Announces Release Date of Third Quarter 2025 Financial Results
Toast (NYSE: TOST), the all-in-one digital technology platform built for restaurants, will release financial results for the third quarter ended September 30, 2025 following the close of the U.S. markets on Tuesday, November 4, 2025. Toast will host a conference call to discuss its results at 5:00 p.m. Eastern Time the same day.
By Toast, Inc. · Via Business Wire · October 21, 2025
AvePoint to Announce Third Quarter 2025 Financial Results on November 6
JERSEY CITY, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in data security, governance, and resilience, will report its third quarter 2025 financial results after the US financial markets close on Thursday, November 6, 2025.
By AvePoint, Inc. · Via GlobeNewswire · October 21, 2025
Intuitive Announces Third Quarter Earnings
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2025.
By Intuitive Surgical, Inc. · Via GlobeNewswire · October 21, 2025
Coupang to Announce Third Quarter 2025 Results on November 4, 2025
Coupang, Inc. (NYSE: CPNG) will release its third quarter 2025 financial results on Tuesday, November 4, 2025. The release will be available after U.S. market close and an accompanying live webcast will begin at 2:30PM PT/ 5:30 PM ET the same day.
By Coupang · Via Business Wire · October 21, 2025
Remitly to Report Third Quarter Financial Results on November 5, 2025
SEATTLE, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report third quarter financial results after the market close on Wednesday, November 5, 2025. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below.
By Remitly, Inc. · Via GlobeNewswire · October 21, 2025
Synchronoss Technologies Announces Third Quarter 2025 Earnings Call Date
BRIDGEWATER, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the third quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call.
By Synchronoss Technologies, Inc. · Via GlobeNewswire · October 21, 2025
Xometry to Announce Third Quarter 2025 Financial Results on November 4, 2025
NORTH BETHESDA, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting buyers and suppliers of custom manufacturing, announced it will report its third quarter 2025 financial results before the market opens on November 4, 2025.
By Xometry, Inc. · Via GlobeNewswire · October 21, 2025
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events
By Terns Pharmaceuticals, Inc. · Via GlobeNewswire · October 21, 2025
Bitfarms Announces Closing of US$500 Million of Convertible Senior Notes
TORONTO, Ontario and NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a North American energy and digital infrastructure company (“Bitfarms” or the “Company”), today announced that it has closed its offering of US$588 million aggregate principal amount of 1.375% convertible senior notes due 2031 (the “Convertible Notes”), which includes the exercise in full of the $88 million option granted to the initial purchasers of the Convertible Notes.
By Bitfarms Ltd. · Via GlobeNewswire · October 21, 2025
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced results from the Phase 3 INFRONT-3 clinical trial evaluating latozinemab (AL001) in individuals with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN).
By Alector, Inc. · Via GlobeNewswire · October 21, 2025
Magnachip to Announce Third Quarter 2025 Financial Results on November 3, 2025
Magnachip Semiconductor Corporation ("Magnachip") (NYSE: MX) announced today that it will report its financial results for the third quarter ended September 30, 2025, on Monday, November 3, 2025, after the market closes. The Company will host a corresponding conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results.
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4, 2025. John Aballi, Exagen’s President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call to review the company’s results at 8:30 a.m. ET (5:30 a.m. PT).
By Exagen Inc. · Via GlobeNewswire · October 21, 2025
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2025 after the close of trading on Tuesday, November 4, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 4, 2025.
By Ceribell · Via GlobeNewswire · October 21, 2025
The Stuart Piltch Award for National Security Inspires Future Leaders in Technology and Intelligence Innovation
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / The Stuart Piltch Award for National Security is now accepting applications from undergraduate students who aspire to make meaningful contributions to the ever-evolving landscape of national security. This prestigious award, founded by Stuart Piltch , recognizes exceptional academic promise, critical thinking, and forward-looking insight into the challenges and opportunities at the intersection of technology and national defense.
Via ACCESS Newswire · October 21, 2025
Children’s Hospital Los Angeles Bariatric Surgery Program Earns National Accreditation from the American College of Surgeons
The Bariatric Surgery Program at Children’s Hospital Los Angeles (CHLA) has been nationally accredited by the American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), placing it among a distinguished group of pediatric centers recognized for excellence in bariatric surgical care for youth with obesity. With this designation, CHLA becomes one of only eight pediatric centers in the country to receive this accreditation.
By Children’s Hospital Los Angeles · Via Business Wire · October 21, 2025
In Vilnius’ Paupys District, a Barbershop Becomes a Must-Visit Stop for Style, Coffee, and Culture
Vilnius Barbershop continues to attract attention as one of Vilnius’ standout destinations for men’s grooming and style.Located in the heart of the city’s creative Paupys district, the barbershop has become a favorite for both locals and travelers seeking precision cuts, beard styling, and an authentic Vilnius experience along the Vilnelė riverbank.
Via AB Newswire · October 21, 2025
Dr. Michael Lebow Launches Healthcare Made-Easy Grant for Aspiring Healthcare Professionals
ATLANTA, GA / ACCESS Newswire / October 21, 2025 / Dr. Michael Lebow , a nationally recognized vascular surgeon, announces the launch of the Dr. Michael Lebow Healthcare Made-Easy Grant aimed at supporting the next generation of healthcare leaders. This annual scholarship is designed for undergraduate students who are pursuing careers in healthcare, with a focus on enhancing accessibility and innovation in patient care.
Via ACCESS Newswire · October 21, 2025
Ibotta To Announce Third Quarter 2025 Financial Results on November 12, 2025
Ibotta (NYSE: IBTA), which operates the largest digital promotions network in North America, announced today that it will report third quarter 2025 financial results after the market closes on Wednesday, November 12, 2025. Management will host a conference call and webcast to discuss Ibotta’s financial results, recent developments, and business outlook at 2:30 p.m. MT/4:30 p.m. ET following the release of the financial results.
By Ibotta · Via Business Wire · October 21, 2025
KBRA Assigns Preliminary Ratings to MSBAM 2025-5C2
KBRA is pleased to announce the assignment of preliminary ratings to 35 classes of MSBAM 2025-5C2, a $713.6 CMBS conduit transaction collateralized by 35 commercial mortgage loans secured by 164 properties. The collateral properties are located throughout 39 MSAs, of which the three largest are New York (32.0% of pool balance), Boston (11.9%), and Seattle (7.5%). The pool has exposure to all major property types, with four types representing more than 10.0% of the pool balance: multifamily (31.0%), mixed-use (27.3%), and office (11.1%). The loans have in-trust principal balances ranging from $2.7 million to $71.0 million for the largest loan in the pool, The MC (10.0%), a Class-A, mixed-use multifamily/retail complex located in the Bedford-Stuyvesant neighborhood of New York City's borough of Brooklyn. The five largest loans, which also include Vertex HQ (9.1%%), Terra Apartments (7.7%), Sterling Plaza (7.5%), and The Depot at Nickel Plate (5.1%), represent 39.3% of the initial pool balance, while the top 10 loans represent 59.4%.
By Kroll Bond Rating Agency, LLC · Via Business Wire · October 21, 2025
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, RAPT expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of shares of common stock RAPT is offering, at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by RAPT. The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering.
By RAPT Therapeutics, Inc. · Via GlobeNewswire · October 21, 2025
Strategic Acquisition Expands Industrial Platform and Talent Base
JACKSONVILLE, FL / ACCESS Newswire / October 21, 2025 / FRP Holdings, Inc. (NASDAQ:FRPH) announced today that the Company has completed the closing on its Purchase and Sales Agreement to acquire the business operations and development pipeline of Altman Logistics Properties, LLC, an operating platform of BBX Capital. Altman Logistics holds minority interests in a portfolio of institutional-grade industrial assets under various stages of development (including the Company's industrial developments in Lakeland and Broward County, FL) as well as a contract for the purchase of an industrial land parcel.
Via ACCESS Newswire · October 21, 2025
Micron Announces Board of Directors Retirements
BOISE, Idaho, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced that Richard M. Beyer and Mary Pat McCarthy have informed the company that they will retire from its board of directors at the annual shareholders meeting expected to be held on Jan. 15, 2026.
By Micron Technology, Inc. · Via GlobeNewswire · October 21, 2025
Personalis to Announce Third Quarter 2025 Financial Results
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
By Personalis, Inc. · Via Business Wire · October 21, 2025
Viridian Therapeutics Announces Proposed Underwritten Public Offering
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and Series B non-voting convertible preferred stock. All of the securities to be sold in the underwritten public offering are being offered by Viridian. In addition, Viridian intends to grant the underwriters a 30-day option to purchase additional shares of its common stock. Each share of Series B preferred stock will be convertible into 66.67 shares of common stock at the election of the holder, subject to beneficial ownership conversion limits applicable to the Series B preferred stock. Viridian intends to use the proceeds from the proposed underwritten public offering of its shares of common stock and Series B preferred stock, together with its cash, cash equivalents and short-term investments, to fund the company’s commercial launch activities related to veligrotug and VRDN-003 and research and development activities, as well as for working capital and general corporate purposes.
By Viridian Therapeutics, Inc. · Via Business Wire · October 21, 2025
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 4, 2025 to report its third quarter 2025 financial results and provide a corporate update.
By Rhythm Pharmaceuticals, Inc. · Via GlobeNewswire · October 21, 2025
Nutex Health Inc. Class Action: Levi & Korsinsky Reminds Nutex Health Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 21, 2025 - NUTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Semler Scientific, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SMLR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Lantheus Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LNTH
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Investors in Fortinet, Inc. Should Contact Levi & Korsinsky Before November 21, 2025 to Discuss Your Rights - FTNT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Lost Money on Fly-E Group, Inc. (FLYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Lost Money on LifeMD, Inc. (LFMD)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Class Action Filed Against Tronox Holdings plc (TROX) - November 3, 2025 Deadline to Join - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Contact Levi & Korsinsky by November 7, 2025 Deadline to Join Class Action Against Savara Inc. (SVRA)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Investors in Fluor Corporation Should Contact Levi & Korsinsky Before November 14, 2025 to Discuss Your Rights - FLR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
RCI Hospitality Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 20, 2025 to Discuss Your Rights - RICK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Dow Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - DOW
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Class Action Filed Against WPP plc (WPP) Seeking Recovery for Investors - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Shareholders of V.F. Corporation Should Contact Levi & Korsinsky Before November 12, 2025 to Discuss Your Rights - VFC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Levi & Korsinsky Notifies KBR, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - KBR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Contact Levi & Korsinsky by October 21, 2025 Deadline to Join Class Action Against C3.ai, Inc. (AI)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 21, 2025
Lost Money on LifeMD, Inc. (LFMD)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. (NASDAQ: LFMD) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025
Class Action Filed Against Tronox Holdings plc (TROX) - November 3, 2025 Deadline to Join - Contact Levi & Korsinsky
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Tronox Holdings plc (NYSE: TROX) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025
Contact Levi & Korsinsky by November 7, 2025 Deadline to Join Class Action Against Savara Inc. (SVRA)
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Savara Inc. (NASDAQ: SVRA) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025
Investors in Fluor Corporation Should Contact Levi & Korsinsky Before November 14, 2025 to Discuss Your Rights - FLR
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Fluor Corporation (NYSE: FLR) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025
RCI Hospitality Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 20, 2025 to Discuss Your Rights - RICK
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RCI Hospitality Holdings, Inc. (NASDAQ: RICK) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025
Dow Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - DOW
NEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Dow Inc. (NYSE: DOW) of a class action securities lawsuit.
Via TheNewswire.com · October 21, 2025